7 assets in Nervous System Neoplasm

Therapeutic assets addressing Nervous System Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Carboplatin Nervous System Neoplasm	Blueprint Medicines Corporation	P3	BB (64)
Microbubble Nervous System Neoplasm	NaviFUS Corporation	P3	B (60)
Sulfur Hexafluoride Nervous System Neoplasm	NaviFUS Corporation	P1/2	CC (47)
Blu-701 Nervous System Neoplasm	Blueprint Medicines Corporation	P1	CC (43)
G 207 Nervous System Neoplasm	M.D. Anderson Cancer Center	P1	CC (43)
Osimertinib Nervous System Neoplasm	Blueprint Medicines Corporation	P1	CC (43)